SpyGlass Pharma, Inc. (SGP) › Cash & EquivalentsSpyGlass Pharma, Inc. (SGP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $16.27M2025: $96.36M$96.36M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$96.36M+492.3%2024$16.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share